2025/06/01 更新

写真a

イトウ トモヤ
伊藤 智哉
ITO TOMOYA
所属
薬学研究院 臨床薬学部門 助教
薬学部 臨床薬学科(併任)
薬学府 臨床薬学専攻(併任)
職名
助教
連絡先
メールアドレス
電話番号
0926426585

研究分野

  • ライフサイエンス / 分子生物学

学位

  • 博士(理学)

経歴

  • 九州大学 大学院薬学研究院 助教 

    2024年4月 - 現在

      詳細を見る

  • 2014.10 - 2014.12 東京工業大学 バイオ研究基盤支援総合センター 教育支援員 2015.01 - 2015.03 京都大学大学院工学研究科 合成・生物化学専攻 教務補佐員 2015.04 - 2016.09 自然科学研究機構生理学研究所 生体情報研究系 心循環シグナル研究部門 博士研究員(NIPS リサーチフェロー) 2016.10 - 2024.03 英国ロンドン大学クイーン・メアリー校ウィリアム・ハーベイ研究所 博士研究員   

論文

  • TRP channels in cardiac mechano-redox coupling and diseases 国際誌

    Mi X., Wu D., Ito T., Kato Y., Nishimura A., Nishida M.

    Journal of Cardiology   2025年2月   ISSN:09145087

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Cardiology  

    Reactive oxygen species (ROS) produced by mechanically stretching cardiomyocytes is a crucial mediator to increase contractile force in accordance with the Frank-Starling law. However, excessive ROS production leads to oxidative stress, contributing to myocardial atrophic remodeling and cellular damage. NADPH oxidase, the primary enzyme responsible for ROS production localized on the plasma membrane and organelle membranes, plays a key role in membrane-oriented ROS signaling. Two isoforms of NADPH oxidase, Nox2 (constitutive) and Nox4 (inducible), are predominantly expressed in cardiomyocytes, each playing unique roles in different contexts. Recent studies have revealed that Nox proteins form protein signaling complexes with transient receptor potential (TRP) channel proteins, amplifying ROS signaling in hearts. This review presents the putative mechanism of protein-protein interaction between TRP and Nox and their pathophysiological significance in hearts and discusses therapeutic strategies targeting TRP-Nox protein interactions for the treatment of heart failure.

    DOI: 10.1016/j.jjcc.2025.02.016

    Scopus

    PubMed

    researchmap

  • Ligand-Independent Spontaneous Activation of Purinergic P2Y<inf>6</inf> Receptor Under Cell Culture Soft Substrate

    Nishimura A., Nishiyama K., Ito T., Mi X., Kato Y., Inoue A., Aoki J., Nishida M.

    Cells   14 ( 3 )   2025年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Cells  

    G protein-coupled receptors (GPCRs) exist in the conformational equilibrium between inactive state and active state, where the proportion of active state in the absence of a ligand determines the basal activity of GPCRs. Although many GPCRs have different basal activity, it is still unclear whether physiological stresses such as substrate stiffness affect the basal activity of GPCRs. In this study, we identified that purinergic P2Y6 receptor (P2Y6R) induced spontaneous Ca2+ oscillation without a nucleotide ligand when cells were cultured in a silicon chamber. This P2Y6R-dependent Ca2+ oscillation was absent in cells cultured in glass dishes. Coating substrates, including collagen, laminin, and fibronectin, did not affect the P2Y6R spontaneous activity. Mutation of the extracellular Arg-Gly-Asp (RGD) motif of P2Y6R inhibited spontaneous activity. Additionally, extracellular Ca2+ was required for P2Y6R-dependent spontaneous Ca2+ oscillation. The GPCR screening assay identified cells expressing 10 GPCRs, including purinergic P2Y1R, P2Y2R, and P2Y6R, that exhibited spontaneous Ca2+ oscillation under cell culture soft substrate. Our results suggest that stiffness of the cell adhesion surface modulates spontaneous activities of several GPCRs, including P2Y6R, through a ligand-independent mechanism.

    DOI: 10.3390/cells14030216

    Scopus

    PubMed

    researchmap

  • TRPC6-Mediated Zn<sup>2+</sup> Influx Negatively Regulates Contractile Differentiation of Vascular Smooth Muscle Cells

    Su C., Mi X., Ito T., Kato Y., Nishimura A., Nagata R., Mori Y., Nishida M.

    Biomolecules   15 ( 2 )   2025年2月

     詳細を見る

    記述言語:英語   出版者・発行元:Biomolecules  

    Vascular smooth muscle cells (VSMCs) can dynamically change their phenotype between contractile and synthetic forms in response to environmental stress, which is pivotal in maintaining vascular homeostasis and mediating pathological remodeling of blood vessels. We previously reported that suppression of canonical transient receptor potential 6 (TRPC6) channel-mediated cation entry sustains VSMCs contractile phenotype and promotes the blood flow recovery after hindlimb ischemia in mice. We also reported that Zn2+, a metal biomolecule mobilized by TRPC6 channel activation, exerts potential beneficial effects on cardiac contractility and remodeling. Therefore, we hypothesized that TRPC6-mediated Zn2+ influx participates in phenotype switching of VSMCs and vascular remodeling. We established rat aortic smooth muscle cells (RAoSMCs) stably expressing wild type (WT) and Zn2+ only impermeable TRPC6 (KYD) mutant. Although the resting phenotypes were similar in both RAoSMCs, pharmacological TRPC6 activation by PPZ2 prevented the transforming growth factor (TGF) β-induced reduction in the intracellular Zn2+ amount and contractile differentiation in RAoSMCs (WT), but failed to prevent them in RAoSMCs (KYD). There were no significant differences in TRPC6-dependent cation currents among all RAoSMCs pretreated with or without TGFβ and/or PPZ2, suggesting that TRPC6 channels are functionally expressed in RAoSMCs regardless of their phenotype. Treatment of mice with PPZ2 attenuated the progression of vascular remodeling caused by chronic angiotensin II infusion. These results suggest that Zn2+ influx through TRPC6 channels negatively regulates the TGFβ-induced contractile differentiation of VSMCs and the progression of vascular remodeling in rodents.

    DOI: 10.3390/biom15020267

    Scopus

    PubMed

  • Inorganic sulfides prevent osimertinib-induced mitochondrial dysfunction in human iPS cell-derived cardiomyocytes 査読

    Kondo, M; Nakamura, Y; Kato, Y; Nishimura, A; Fukata, M; Moriyama, S; Ito, T; Umezawa, K; Urano, Y; Akaike, T; Akashi, K; Kanda, Y; Nishida, M

    JOURNAL OF PHARMACOLOGICAL SCIENCES   156 ( 2 )   69 - 76   2024年10月   ISSN:1347-8613 eISSN:1347-8648

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Pharmacological Sciences  

    Despite the widespread recognition of the global concern regarding the onset of cardiovascular diseases in a significant number of patients following cancer treatment, definitive strategies for prevention and treatment remain elusive. In this study, we established systems to evaluate the influence of anti-cancer drugs on the quality control of mitochondria, pivotal for energy metabolism, using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Osimertinib, an epidermal growth factor receptor tyrosine kinase inhibitor used for treatment in lung cancer, reportedly increases the risk of cardiovascular disease. However, its underlying mechanism is largely unknown. Here, we found that the treatment of hiPSC-CMs with osimertinib and doxorubicin, but not trastuzumab and cisplatin, revealed a concentration-dependent impairment of respiratory function accompanied by mitochondrial fission. We previously reported the significant role of sulfur metabolism in maintaining mitochondrial quality in the heart. Co-treatment with various inorganic sulfur donors (Na2S, Na2S2, Na2S3) alongside anti-cancer drugs demonstrated that Na2S attenuated the cardiotoxicity of osimertinib but not doxorubicin. Osimertinib decreased intracellular reduced sulfur levels, while Na2S treatment suppressed the sulfur leakage, suggesting its potential in mitigating osimertinib-induced cardiotoxicity. These results imply the prospect of inorganic sulfides, such as Na2S, as a seed for precision pharmacotherapy to alleviate osimertinib's cardiotoxic effects.

    DOI: 10.1016/j.jphs.2024.07.007

    Web of Science

    Scopus

    PubMed

    researchmap

  • 無機硫化物はヒトiPS細胞由来心筋細胞におけるオシメルチニブ誘発性ミトコンドリア機能障害を防止する(Inorganic sulfides prevent osimertinib-induced mitochondrial dysfunction in human iPS cell-derived cardiomyocytes)

    Kondo Moe, Nakamura Yuya, Kato Yuri, Nishimura Akiyuki, Fukata Mitsuhiro, Moriyama Shohei, Ito Tomoya, Umezawa Keitaro, Urano Yasuteru, Akaike Takaaki, Akashi Koichi, Kanda Yasunari, Nishida Motohiro

    Journal of Pharmacological Sciences   156 ( 2 )   69 - 76   2024年10月   ISSN:1347-8613

     詳細を見る

    記述言語:英語   出版者・発行元:(公社)日本薬理学会  

    ヒト人工多能性幹細胞由来心筋細胞(hiPSC-CM)を用いて、ミトコンドリアに対する抗癌剤の影響を評価するためのシステムを作成した。hiPSC-CMをオシメルチニブ(Ost)とドキソルビシンで処理した結果、ミトコンドリア分裂を伴う呼吸機能障害が認められた。以前の報告を元に無機イオウドナー(Na2S、Na2S2、Na2S3)を抗癌剤と一緒に投与した。その結果、Na2SはOstの心毒性を弱めたが、ドキソルビシンの毒性は弱めなかった。Ostは細胞内の硫黄濃度を低下させ、Na2Sは硫黄の流出を抑制したことから、その作用がOstの心毒性を和らげることが示唆された。以上より、無機硫化物がOstの心毒性を緩和する薬物療法のシーズとして期待しうると考えられた。

▼全件表示

講演・口頭発表等

MISC

担当授業科目

  • 薬理・疾患治療

    2025年10月 - 2026年3月   後期

  • 生理学

    2025年6月 - 2025年8月   夏学期

  • 薬学基礎実習Ⅳ

    2025年6月 - 2025年8月   夏学期

  • 医療薬学演習Ⅰ

    2025年4月 - 2025年9月   前期

  • 医療薬学演習Ⅱ

    2025年4月 - 2025年9月   前期

▼全件表示